EFFICACY OF PLERIXAFOR IN CD34+ STEM CELL MOBILIZATION IN HEALTHY PEDIATRIC STEM CELL DONORS

被引：0
|
作者：
Bharadwaj, Rishab [1 ]
Kumar, Vimal [1 ]
Munirathnam, Deenadayalan [1 ]
机构：
[1] Dr Rela Inst & Med Ctr, Chennai, Tamil Nadu, India
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P724
引用
收藏
页码：644 / 644
页数：1
相关论文
共 50 条
  • [31] Peripheral blood stem cell mobilization from healthy donors
    Ozkan, Melda Comert
    Sahin, Fahri
    Saydam, Guray
    TRANSFUSION AND APHERESIS SCIENCE, 2015, 53 (01) : 13 - 16
  • [32] Stem cell mobilization and collection from patients and healthy donors
    Unal, Ali
    TRANSFUSION AND APHERESIS SCIENCE, 2015, 53 (01) : 1 - 2
  • [33] HEMATOPOIETIC RECOVERY AFTER STEM-CELL TRANSPLANTATION - IMPACT OF CD34+ CELL DOSE AND METHOD OF MOBILIZATION
    BORSON, R
    BROWN, R
    HENDRICKS, D
    EHLENBECK, C
    DIPERSIO, JF
    BLOOD, 1994, 84 (10) : A349 - A349
  • [34] Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts
    Rutella, Sergio
    Filippini, Perla
    Bertaina, Valentina
    Li Pira, Giuseppina
    Altomare, Lidia
    Ceccarelli, Stefano
    Brescia, Letizia P.
    Lucarelli, Barbarella
    Girolami, Elia
    Conflitti, Gianpiero
    Cefalo, Maria Giuseppina
    Bertaina, Alice
    Corsetti, Tiziana
    Moretta, Lorenzo
    Locatelli, Franco
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [35] Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts
    Sergio Rutella
    Perla Filippini
    Valentina Bertaina
    Giuseppina Li Pira
    Lidia Altomare
    Stefano Ceccarelli
    Letizia P Brescia
    Barbarella Lucarelli
    Elia Girolami
    Gianpiero Conflitti
    Maria Giuseppina Cefalo
    Alice Bertaina
    Tiziana Corsetti
    Lorenzo Moretta
    Franco Locatelli
    Journal of Translational Medicine, 12
  • [36] Hematopoietic stem cell mobilization with plerixafor in sickle cell disease
    Hsieh, Matthew M.
    Tisdale, John F.
    HAEMATOLOGICA, 2018, 103 (05) : 749 - 750
  • [37] PRELIMINARY EXPERIENCE WITH PLERIXAFOR FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN PEDIATRIC PATIENTS
    Hawks, R. G.
    Semidei-Pomales, M.
    Abendroth, H. E.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S197 - S197
  • [38] Platelet count before stem cell mobilization is associated with the need for plerixafor but not with CD34+collection result
    Baertsch, M. -A
    Lisenko, K.
    Pavel, P.
    Bruckner, T.
    Hundemer, M.
    Ho, A. D.
    Goldschmidt, H.
    Wuchter, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 276 - 276
  • [39] Prediction of CD34+hematopoietic stem cells in healthy allogeneic stem cell donors on the Optia cell separator based on CE2: Which formula is more correlated with actual CD34+?
    Ozkan, Sidika Gulkan
    Kimiaei, Ali
    Safaei, Seyedehtina
    Ercan, Tarik
    Sonmezoglu, Meral
    Demirel, Gulderen Yanikkaya
    Aktas, Sema
    Ozdemir, Sinem
    Ozalp, Helin Serda
    Ozkan, Hasan Atilla
    TRANSFUSION, 2024, 64 (10) : 1959 - 1967
  • [40] Evaluation of CD34+ Cell Count at Different Time Points Following Plerixafor Administration in Autologous Hematopoietic Stem Cell Transplantation
    Ardakani, Maria Tavakoli
    Ahadi, Hamid Reza
    Bonakchi, Hossein
    Parkhideh, Sayeh
    Tavakoli, Farzaneh
    Moshari, Mohammad Reza
    Soleimani, Masoud
    Hajifathali, Abbas
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2022, 15 (06)
12345